Publications by authors named "Steve Hass"

Claim this Profile
C
Characterizing the treatment patterns, medication burden, and patient demographics of older adults with major depressive disorder treated with antidepressants with or without selected comorbidities.
Laxmi Gannu, Francesca Devine, Lyuba Popadic, Sagar Lal, Michael Witte, Steve Hass

Curr Med Res Opin· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe.
Lynn Huynh, Steve Hass, Laurent Peyrin-Biroulet, Mei Sheng Duh, Heather Sipsma

Crohns Colitis 360· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Parent Preferences for Peanut Desensitization Therapy.
Anna Hung, Juan Marcos Gonzalez, Jui-Chen Yang, Steve Hass, Edwin Kim

J Allergy Clin Immunol Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk Reduction of Accidental Exposure-Related Systemic Allergic Reactions Extrapolated Based on Food Challenge Data After 1 Year of Peanut Oral Immunotherapy.
Shengsheng Yu, Alex Smith, Steve Hass, Eric Wu, Xinglei Chai

Adv Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
J Allen Meadows, Shengsheng Yu, Steve L Hass, Annie Guerin, Dominick Latremouille-Viau

Allergy Asthma Proc· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States.
Michael S Blaiss, J Allen Meadows, Shengsheng Yu, Dan R Robison, Steve L Hass

J Manag Care Spec Pharm· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff Preferences.
Jui-Chen Yang, Shelby D Reed, Steve Hass, Mark B Skeen, F Reed Johnson

Med Decis Making· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life evaluation of crohn disease patients after receiving natalizumab therapy.
Sharon Dudley-Brown, Arpita Nag, Cory Cullinan, Mary Ayers, Steve Hass

Gastroenterol Nurs· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
Josh Marehbian, H Michael Arrighi, Steve Hass, Haijun Tian, William J Sandborn

Am J Gastroenterol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.
F Reed Johnson, George Van Houtven, Semra Ozdemir, Steve Hass, Jeff White

J Neurol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in multiple sclerosis: effects of natalizumab.
Richard A Rudick, Deborah Miller, Steve Hass, Michael Hutchinson, Peter A Calabresi

Ann Neurol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis